• Je něco špatně v tomto záznamu ?

TLR2 in pleural fluid is modulated by talc particles during pleurodesis

K. Jankovicova, K. Kondelkova, P. Habal, C. Andrys, J. Krejsek, J. Mandak,

. 2012 ; 2012 () : 158287.

Jazyk angličtina Země Egypt

Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13031725

The aim of this study was to examine the role of TLR2 molecule in pleural space during thoracoscopic talc pleurodesis period in patients with malignant pleural effusion. We analyzed TLR2 molecule in soluble form as well as on membrane of granulocytes in pleural fluid. Pleural fluid examination was done at three intervals during pleurodesis procedure: 1st-before the thoracoscopic procedure, 2nd-2 hours after the terminating thoracoscopic procedure with talc insufflation, 3rd-24 hours after the thoracoscopic procedure. We reported significant increase of soluble TLR2 molecule in pleural fluid effusion during talc pleurodesis from preoperative value. This increase was approximately 8-fold in the interval of 24 hours. The changes on granulocyte population were quite different. The mean fluorescent intensity of membrane TLR2 molecule examined by flow cytometry on granulocyte population significantly decreased after talc exposure with comparison to prethoracoscopic density. To estimate the prognostic value of TLR2 expression in pleural fluid patients were retrospectively classified into either prognostically favourable or unfavourable groups. Our results proved that patients with favourable prognosis had more than 3-fold higher soluble TLR2 level in pleural fluid early, 2 hours after talc pleurodesis intervention.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031725
003      
CZ-PrNML
005      
20131004094104.0
007      
ta
008      
131002s2012 ua f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2012/158287 $2 doi
035    __
$a (PubMed)23304186
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ua
100    1_
$a Jankovicova, Karolina $u Department of Clinical Immunology and Allergy, Faculty of Medicine and University Hospital in Hradec Kralove, Charles University in Prague, Sokolska Street 581, 500 05 Hradec Kralove, Czech Republic. karolina.jankovicova@fnhk.cz
245    10
$a TLR2 in pleural fluid is modulated by talc particles during pleurodesis / $c K. Jankovicova, K. Kondelkova, P. Habal, C. Andrys, J. Krejsek, J. Mandak,
520    9_
$a The aim of this study was to examine the role of TLR2 molecule in pleural space during thoracoscopic talc pleurodesis period in patients with malignant pleural effusion. We analyzed TLR2 molecule in soluble form as well as on membrane of granulocytes in pleural fluid. Pleural fluid examination was done at three intervals during pleurodesis procedure: 1st-before the thoracoscopic procedure, 2nd-2 hours after the terminating thoracoscopic procedure with talc insufflation, 3rd-24 hours after the thoracoscopic procedure. We reported significant increase of soluble TLR2 molecule in pleural fluid effusion during talc pleurodesis from preoperative value. This increase was approximately 8-fold in the interval of 24 hours. The changes on granulocyte population were quite different. The mean fluorescent intensity of membrane TLR2 molecule examined by flow cytometry on granulocyte population significantly decreased after talc exposure with comparison to prethoracoscopic density. To estimate the prognostic value of TLR2 expression in pleural fluid patients were retrospectively classified into either prognostically favourable or unfavourable groups. Our results proved that patients with favourable prognosis had more than 3-fold higher soluble TLR2 level in pleural fluid early, 2 hours after talc pleurodesis intervention.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a granulocyty $x účinky léků $x metabolismus $7 D006098
650    _2
$a lidé $7 D006801
650    _2
$a insuflace $x metody $7 D007327
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pleura $x účinky léků $x metabolismus $7 D010994
650    _2
$a maligní pleurální výpotek $x metabolismus $x terapie $7 D016066
650    _2
$a pleurodéza $x metody $7 D018700
650    _2
$a prognóza $7 D011379
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a mastek $x aplikace a dávkování $7 D013627
650    _2
$a torakoskopie $x metody $7 D013906
650    _2
$a toll-like receptor 2 $x metabolismus $7 D051195
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kondelkova, Katerina $u -
700    1_
$a Habal, Petr $u -
700    1_
$a Andrýs, Ctirad $u - $7 mzk2008430528
700    1_
$a Krejsek, Jan $u -
700    1_
$a Mandak, Jiri $u -
773    0_
$w MED00013777 $t Clinical & developmental immunology $x 1740-2530 $g Roč. 2012(2012), s. 158287
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23304186 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20131004094623 $b ABA008
999    __
$a ok $b bmc $g 995812 $s 830170
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 2012 $d 158287 $i 1740-2530 $m Clinical & developmental immunology $n Clin Dev Immunol $x MED00013777
LZP    __
$a Pubmed-20131002

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...